Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Marinus Pharmaceuticals fell by 119.98m. Cash Flow from Financing totalled 26.63m or 85.92% of revenues. In addition the company used 118.00m for operations while cash used for investing totalled 28.61m.
Cash flow per share | -2.65 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.8614 |
---|---|
Tangible book value per share | -0.8614 |
More ▼
Balance sheet in USDView more
Current ratio | 2.28 |
---|---|
Quick ratio | 2.15 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 6.10 |
More ▼